Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study.
Saved in:
| Title: | Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study. |
|---|---|
| Authors: | Pedersen M; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Westergaard MCW; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Milne K; Deeley Research Centre, BC Cancer, Victoria, Canada., Nielsen M; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Borch TH; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Poulsen LG; Department of Gynecology and Obstetrics, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Hendel HW; Department of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Kennedy M; Deeley Research Centre, BC Cancer, Victoria, Canada., Briggs G; Deeley Research Centre, BC Cancer, Victoria, Canada., Ledoux S; Deeley Research Centre, BC Cancer, Victoria, Canada., Nøttrup TJ; Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Andersen P; Department of Clinical Immunology and Stem Cell Facility, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Hasselager T; Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Met Ö; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, Canada., Donia M; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark., Svane IM; Center for Cancer Immune Therapy, Department of Hematology, Herlev Hospital, University of Copenhagen, Herlev, Denmark.; Department of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark. |
| Source: | Oncoimmunology [Oncoimmunology] 2018 Sep 26; Vol. 7 (12), pp. e1502905. Date of Electronic Publication: 2018 Sep 26 (Print Publication: 2018). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-4011 |
|---|---|
| DOI: | 10.1080/2162402X.2018.1502905 |
